BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25912275)

  • 1. Patient-Reported Outcomes for Determining Prognostic Groups in Veterans With Advanced Cancer.
    Chang VT; Scott CB; Gonzalez ML; Einhorn J; Yan H; Kasimis BS
    J Pain Symptom Manage; 2015 Sep; 50(3):313-20. PubMed ID: 25912275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress.
    Hwang SS; Scott CB; Chang VT; Cogswell J; Srinivas S; Kasimis B
    Cancer Invest; 2004; 22(5):678-87. PubMed ID: 15581048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
    LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
    J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
    Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
    Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying prognostic factors for survival in advanced cancer patients: a prospective study.
    Lam PT; Leung MW; Tse CY
    Hong Kong Med J; 2007 Dec; 13(6):453-9. PubMed ID: 18057434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter?
    Efficace F; Cartoni C; Niscola P; Tendas A; Meloni E; Scaramucci L; Soldati S; Brunetti GA; Marini MG; Mandelli F
    Eur J Haematol; 2012 Nov; 89(5):410-6. PubMed ID: 22985353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness and prognostic value of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in assessment of lung cancer patients.
    Bircan HA; Yalcin GS; Fidanci S; Karaibrahimoglu A; Tuglu HC
    Support Care Cancer; 2020 Apr; 28(4):2005-2014. PubMed ID: 31388746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center.
    Hwang SS; Chang VT; Cogswell J; Kasimis BS
    Cancer; 2002 May; 94(9):2481-9. PubMed ID: 12015774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple prognostic model for patients with advanced cancer based on performance status.
    Jang RW; Caraiscos VB; Swami N; Banerjee S; Mak E; Kaya E; Rodin G; Bryson J; Ridley JZ; Le LW; Zimmermann C
    J Oncol Pract; 2014 Sep; 10(5):e335-41. PubMed ID: 25118208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should patient-rated performance status affect treatment decisions in advanced lung cancer?
    Dajczman E; Kasymjanova G; Kreisman H; Swinton N; Pepe C; Small D
    J Thorac Oncol; 2008 Oct; 3(10):1133-6. PubMed ID: 18827609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of unmet needs in symptomatic veterans with advanced cancer: incidence, independent predictors and unmet needs outcome model.
    Hwang SS; Chang VT; Cogswell J; Alejandro Y; Osenenko P; Morales E; Srinivas S; Kasimis B
    J Pain Symptom Manage; 2004 Nov; 28(5):421-32. PubMed ID: 15504619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy.
    Pérol M; Ciuleanu TE; Arrieta O; Prabhash K; Syrigos KN; Goksel T; Park K; Kowalyszyn RD; Pikiel J; Lewanski CR; Thomas M; Dakhil S; Kim JH; Karaseva N; Yurasov S; Zimmermann A; Lee P; Carter GC; Reck M; Cappuzzo F; Garon EB
    Lung Cancer; 2016 Mar; 93():95-103. PubMed ID: 26898621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
    Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
    Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer.
    Barney BJ; Wang XS; Lu C; Liao Z; Johnson VE; Cleeland CS; Mendoza TR
    Qual Life Res; 2013 Oct; 22(8):2143-50. PubMed ID: 23371797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults.
    Fega KR; Abel GA; Motyckova G; Sherman AE; DeAngelo DJ; Steensma DP; Galinsky I; Wadleigh M; Stone RM; Driver JA
    J Geriatr Oncol; 2015 Jul; 6(4):288-98. PubMed ID: 26073533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edmonton symptom assessment scale as a prognosticative indicator in patients with advanced cancer.
    Zeng L; Zhang L; Culleton S; Jon F; Holden L; Kwong J; Khan L; Tsao M; Danjoux C; Sahgal A; Barnes E; Chow E
    J Palliat Med; 2011 Mar; 14(3):337-42. PubMed ID: 21254813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment.
    Chang VT; Hwang SS; Feuerman M; Kasimis BS
    Cancer; 2000 Mar; 88(5):1175-83. PubMed ID: 10699909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Reported Functional Status in Outpatients With Advanced Cancer: Correlation With Physician-Reported Scores and Survival.
    Popovic G; Harhara T; Pope A; Al-Awamer A; Banerjee S; Bryson J; Mak E; Lau J; Hannon B; Swami N; Le LW; Zimmermann C
    J Pain Symptom Manage; 2018 Jun; 55(6):1500-1508. PubMed ID: 29496534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.